Nephros (NEPH) Change in Accured Expenses (2010 - 2026)

Nephros' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$791000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 825.69% year-over-year to -$791000.0; the TTM figure through Mar 2026 stood at $124000.0 (down 52.85% YoY), while the FY2025 annual figure was $1.0 million, up 553.1% from the prior year.
• Change in Accured Expenses was -$791000.0 for Q1 2026 at Nephros, down from $367000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $380000.0 in Q3 2025 to a low of -$791000.0 in Q1 2026.
• Historically, Change in Accured Expenses has averaged $21352.9 across 5 years, with a median of $88000.0 in 2022.
• The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses soared 663.64% in 2025, then plunged 825.69% in 2026.
• A 5-year view of Change in Accured Expenses shows it stood at $24000.0 in 2022, then surged by 237.5% to $81000.0 in 2023, then jumped by 201.23% to $244000.0 in 2024, then jumped by 50.41% to $367000.0 in 2025, then sank by 315.53% to -$791000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$791000.0 (Q1 2026), $367000.0 (Q4 2025), and $380000.0 (Q3 2025), per Business Quant data.